KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Petmed Express (PETS) over the last 17 years, with Q4 2025 value amounting to $300000.0.

  • Petmed Express' Share-based Compensation fell 4000.0% to $300000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $1.7 million, marking a year-over-year increase of 13109.26%. This contributed to the annual value of -$6.6 million for FY2025, which is 19565.22% down from last year.
  • Latest data reveals that Petmed Express reported Share-based Compensation of $300000.0 as of Q4 2025, which was down 4000.0% from $200000.0 recorded in Q3 2025.
  • Over the past 5 years, Petmed Express' Share-based Compensation peaked at $1.8 million during Q4 2022, and registered a low of -$8.2 million during Q2 2024.
  • For the 5-year period, Petmed Express' Share-based Compensation averaged around $682700.0, with its median value being $1.2 million (2021).
  • Per our database at Business Quant, Petmed Express' Share-based Compensation surged by 11392.76% in 2022 and then crashed by 56613.64% in 2024.
  • Quarter analysis of 5 years shows Petmed Express' Share-based Compensation stood at $1.4 million in 2021, then increased by 22.92% to $1.8 million in 2022, then dropped by 3.56% to $1.7 million in 2023, then tumbled by 70.71% to $500000.0 in 2024, then plummeted by 40.0% to $300000.0 in 2025.
  • Its last three reported values are $300000.0 in Q4 2025, $200000.0 for Q3 2025, and $600000.0 during Q2 2025.